Aktie 300294 CHINA RESOURCES BOYA BIO-PHARMACEUTICAL GROUP CO.,LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Aktien

300294

CNE100001FF1

300294

Schlusskurs Shenzhen S.E.
Andere Börsenplätze
 00:00:00 26.04.2024 		% 5 Tage % 1. Jan.
31,28 CNY -0,29 % Intraday Chart für China Resources Boya Bio-pharmaceutical Group Co.,Ltd -1,14 % -7,13 %
23.04. China Resources Boya Bio-pharmaceutical Group Co.,Ltd meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
14.03. CR Boya Bio-Pharmaceutical's 2023 Gewinn fällt aufgrund geringerer Einnahmen MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
China Resources Boya Bio-Pharmaceutical Group Co.,Ltd. Approves Cash Dividend for the Year 2023
China Resources Boya Bio-Pharmaceutical Group Co.,Ltd Proposes Cash Dividend
CR Boya Bio-Pharmaceutical's 2023 Profit Falls on Lower Revenue
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CR Boya Bio-Pharmaceutical Signs 29.5 Million Yuan Construction Contract for Blood Products Facility
China Resources Double-Crane Pharmaceutical Co.,Ltd. completed the acqyusution 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd.
CR Boya Bio-Pharmaceutical's January-September Profit Increases
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd for CNY 260 million
China Resources Pharmaceutical Commercial Group Company Limited completed the acquisition of 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd..
China Resources Pharmaceutical Commercial Group Company Limited agreed to acquire 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd. for approximately CNY 360 million.
China Resources Pharmaceutical's Subsidiaries Log Increases in H1 Profits
China Resources Boya's H1 Attributable Profit Jumps 16.9%
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
China Resources Boya Bio-pharmaceutical Group's Q1 Profit Rises
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2022, Payable on 28 April 2023
CR Boya Bio-pharmaceutical Estimates Higher Q1 Profit
China Resources Boya Bio-Pharmaceutical Group Co., Ltd. Proposes Dividend for the Year 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 300294 Aktie
  4. Nachrichten China Resources Boya Bio-pharmaceutical Group Co.,Ltd
  5. Andere Sprachen